FDA Inspection 1214514 — Serafin Morales Murillo, PhD, M.D.
The FDA completed an inspection of Serafin Morales Murillo, PhD, M.D. on July 21, 2023 in Lleida. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lleida (Spain)
Additional Details
Clinical Investigator (CI)